mitiglinide has been researched along with Diabetes Mellitus, Adult-Onset in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.45) | 18.2507 |
| 2000's | 18 (31.03) | 29.6817 |
| 2010's | 37 (63.79) | 24.3611 |
| 2020's | 1 (1.72) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Hasegawa, G; Hirata, A; Kadono, M; Nakajima, H; Okada, H; Okada, Y; Oyamada, H; Tanaka, M; Yamane, T | 1 |
| Akahane, K; Inoue, T; Kiguchi, S; Kobayashi, M; Ojima, K; Takeda, H; Tatemichi, S; Yokoyama, A | 1 |
| Akahane, K; Imai, Y; Inoue, T; Kiguchi, S; Ojima, K; Takeda, H; Tatemichi, S; Yokoyama, A | 1 |
| Arao, T; Mori, H; Okada, Y; Tanaka, K; Tanaka, Y; Torimoto, K | 1 |
| Fujimoto, K; Hamamoto, Y; Hamasaki, A; Honjo, S; Shibayama, Y; Yamaguchi, E | 1 |
| ElMeshad, AN; Mahmoud, DBED; Shukr, MH | 1 |
| Asai, Y; Imai, J; Izumi, T; Kaneko, K; Katagiri, H; Satake, C; Sawada, S; Tanaka, M; Yamada, T; Yamamoto, J | 1 |
| Cho, KY; Kameda, H; Ono, Y | 1 |
| Anno, T; Hashiramoto, M; Hirukawa, H; Kaku, K; Kanda-Kimura, Y; Kawasaki, F; Kimura, T; Matsuki, M; Mune, T; Shimoda, M; Tatsumi, F; Tawaramoto, K | 1 |
| Itoh, H; Kawai, T; Kodani, N; Saisho, Y; Tanaka, K | 1 |
| Phillippe, HM; Wargo, KA | 2 |
| Kawata, T; Matsubara, F; Nagai, Y; Nakamura, Y; Ohshige, T; Ohta, A; Sakai, K; Tanaka, Y; Tenjin, A; Terashima, Y; Tsukiyama, S | 1 |
| Fujioka, Y; Inoue, K; Izawa, S; Kato, M; Matsuzawa, K; Nakanishi, R; Ohkura, H; Ohkura, T; Shiochi, H; Sumi, K; Taniguchi, S; Yamamoto, K; Yamamoto, N | 1 |
| Huh, W; Jung, JA; Kaku, K; Kim, JH; Kim, JR; Ko, JW; Lee, SY | 1 |
| Cho, KY; Nakamura, A; Nomoto, H; Ono, Y | 1 |
| Ishida, H; Osonoi, T; Osonoi, Y; Saito, M; Tamasawa, A | 1 |
| Kamoshima, H; Nakamura, A; Nomoto, H; Ono, Y | 1 |
| Chanda, S; Choudhury, SR; Das, S; Datta, A; Pathak, AN | 1 |
| Akahane, K; Inoue, T; Kiguchi, S; Kobayashi, M; Maruyama, K; Mori, Y; Ojima, K; Yaguchi, A; Yokoyama, A | 1 |
| Ando, K; Nishimura, R; Sakamoto, M; Seo, C; Tsujino, D; Utsunomiya, K | 1 |
| Chen, M; Hu, C; Jia, W | 1 |
| Kato, T; Matsuda, Y; Murakami, T; Muro, S; Nambu, T; Oki, S; Yonemitsu, S | 1 |
| Nakashima, E | 1 |
| Nagai, Y | 1 |
| Baek, JH; Huh, WS; Jin, SM; Jung, JA; Kaku, K; Kim, JH; Kim, JR; Kim, MJ; Ko, JW; Lee, SY | 1 |
| Hirayama, A; Nagao, K; Tani, S | 1 |
| Abbatecola, AM; Armellini, F; Bo, M; D'Amico, F; Desideri, G; Falaschi, P; Greco, A; Guerrini, G; Lattanzio, F; Paolisso, G; Volpe, C | 1 |
| Baik, SH; Cha, BS; Jang, HC; Lee, IK; Lee, KW; Park, TS; Son, JW; Sung, YA; Woo, JT; Yoo, SJ; Yoon, KH | 1 |
| Ihana-Sugiyama, N; Kakei, M; Noda, M; Sugiyama, T; Tsujimoto, T; Yamamoto-Honda, R | 1 |
| Malaisse, WJ | 1 |
| Awata, T; Goto, S; Inoue, I; Katayama, S; Komoda, T; Kurihara, S; Nakano, T; Satoh, K; Shinoda, Y; Yamazaki, M | 1 |
| Akanuma, Y; Kaku, K; Kikuchi, M; Origasa, H; Tanaka, S | 2 |
| Cai, S; Huo, T; Li, F; Lu, X; Xu, J; Zheng, S | 1 |
| Abe, M; Maruyama, N; Maruyama, T; Matsumoto, K; Okada, K | 2 |
| Guo, H; Li, L; Li, Z; Liao, Y; Liu, H; Pan, H; Yan, X; Yang, G; Yang, M | 1 |
| Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH | 1 |
| Boden, G; Li, L; Li, Z; Liao, Y; Wang, B; Yang, G; Yang, M | 1 |
| Fatehi, M; Lang, VY; Light, PE | 1 |
| Hashikata, T; Hatakeyama, Y; Kameda, R; Kitasato, L; Tojo, T; Yamaoka-Tojo, M | 1 |
| Inoue, M | 1 |
| Odawara, M | 1 |
| Kiyono, Y; Kojima, M; Ojima, K | 1 |
| Iwamoto, Y | 1 |
| Ishida, H; Katahira, H | 1 |
| Assaloni, R; Ceriello, A; Da Ros, R; Maier, A; Motz, E; Piconi, L; Quagliaro, L; Zuodar, G | 1 |
| Cerasi, E; Efendic, S; Kaiser, N; Nesher, R; Oprescu, A | 1 |
| Hirose, T | 1 |
| Abe, M; Hara, K; Hirose, T; Kanazawa, A; Kanazawa, Y; Kanno, R; Kawai, J; Kawamori, R; Kumashiro, N; Mita, T; Miwa, S; Motojima, K; Sakai, K; Sakurai, Y; Sato, F; Shimizu, T; Tanaka, Y; Uchino, H; Watada, H; Yamazaki, Y; Yoshihara, T | 1 |
| Aoyagi, I; Fujimori, Y; Fuujimori, Y; Itoh, Y; Kojima, M; Kojima, S; Kusama, H; Mori, Y; Ojima, K; Shibata, N; Tajima, N; Yamazaki, Y | 1 |
| Fujitani, Y; Hirose, T; Kanazawa, Y; Kawamori, R; Kumashiro, N; Shimizu, T; Tanaka, Y; Watada, H; Yoshihara, T | 1 |
| Atsumi, Y; Funae, O; Kawai, T; Nakamura, Y; Oikawa, Y; Shimada, A; Suzuki, R; Watanabe, M; Yajima, K; Yamada, S | 1 |
| Koizumi, T; Komatsu, H; Ohnota, H; Satoh, F | 1 |
| Kikuchi, M | 1 |
| Dunning, BE; Foley, JE; Pratley, RE | 1 |
15 review(s) available for mitiglinide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Mitiglinide for type 2 diabetes treatment.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Isoindoles; Treatment Outcome | 2013 |
Overview of current and upcoming strategies implied for the therapy of type 2 diabetes mellitus.
Topics: Benzhydryl Compounds; Developing Countries; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Feeding Behavior; Glucosides; Health Knowledge, Attitudes, Practice; Humans; Hypoglycemic Agents; Inositol; Isoindoles; Nanotechnology; Prevalence; Risk Reduction Behavior; Stem Cell Transplantation; Urbanization | 2014 |
Pharmacogenomics of glinides.
Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Inactivation, Metabolic; Insulin; Insulin Secretion; Insulin-Secreting Cells; Isoindoles; KATP Channels; Nateglinide; Pharmacogenetics; Phenylalanine; Piperidines | 2015 |
Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients.
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glucose; Hepatocytes; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Ion Channels; Islets of Langerhans; Isoindoles; Myocardium | 2008 |
Mitiglinide: a novel agent for the treatment of type 2 diabetes mellitus.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Isoindoles | 2010 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hypoglycemic Agents; Isoindoles; Postprandial Period; Treatment Outcome | 2012 |
[Nateglinide and mitiglinide].
Topics: Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Resistance; Insulin Secretion; Isoindoles; Metformin; Nateglinide; Phenylalanine; Postprandial Period; Stimulation, Chemical | 2003 |
Mitiglinide: KAD 1229, S 21403.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Indoles; Isoindoles; Randomized Controlled Trials as Topic | 2004 |
[Selection of oral antidiabetic drugs].
Topics: Acarbose; Administration, Oral; Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Indoles; Isoindoles; Risk; Sulfonylurea Compounds; Thiazolidinediones | 2005 |
[Effects of mitiglinide in treatment of impaired glucose tolerance].
Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Postprandial Period; Potassium Channels; Stimulation, Chemical | 2005 |
[Significance of insulin secretion pattern lectured by "glinides" in the treatment of postprandial hyperglycemia].
Topics: Cyclohexanes; Diabetes Mellitus, Type 2; Eating; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine | 2005 |
[A rapid- and short-acting insulinotropic agent KAD-1229].
Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors; Time Factors | 1997 |
[Non-SU, insulin secretagogues].
Topics: Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Indoles; Isoindoles; Nateglinide; Phenylalanine | 1999 |
Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.
Topics: Animals; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Piperidines | 2001 |
25 trial(s) available for mitiglinide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Comparison of the Efficacy of Repaglinide Versus the Combination of Mitiglinide and Voglibose on Glycemic Variability in Japanese Patients with Type 2 Diabetes.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Inositol; Isoindoles; Japan; Piperidines | 2020 |
Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial.
Topics: Adult; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Inositol; Isoindoles; Male; Middle Aged; Postprandial Period; Sulfonylurea Compounds; Treatment Outcome | 2018 |
Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Combinations; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Isoindoles; Japan; Lipids; Male; Middle Aged; Postprandial Period; Treatment Outcome | 2013 |
Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Isoindoles; Male; Metformin; Middle Aged; Prognosis | 2013 |
Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2013 |
The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Hypoglycemic Agents; Insulin; Isoindoles; Male; Middle Aged; Molecular Targeted Therapy; Postprandial Period; Proinsulin; Sulfonylurea Compounds; Triglycerides | 2013 |
Additive postprandial glucose-lowering effects of mitiglinide and sitagliptin in patients with type 2 diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Confidence Intervals; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Isoindoles; Male; Middle Aged; Postprandial Period; Prospective Studies; Pyrazines; Reference Values; Severity of Illness Index; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2013 |
Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study.
Topics: Acarbose; Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Drug Substitution; Drug Therapy, Combination; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Isoindoles; Male; Middle Aged; Prospective Studies; Pyrazines; Serum Albumin; Sitagliptin Phosphate; Triazoles | 2014 |
Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose c
Topics: Aged; Blood Glucose; Breakfast; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Insulin Secretion; Isoindoles; Lunch; Male; Meals; Middle Aged; Postprandial Period | 2014 |
Comparing postprandial efficacy in type 2 diabetic patients receiving mitiglinide and sitagliptin by using continuous glucose monitoring: a pilot study.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Isoindoles; Middle Aged; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2014 |
Add-on treatment with mitiglinide improves residual postprandial hyperglycemia in type 2 diabetic patients receiving the combination therapy with insulin glargine and sitagliptin.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Humans; Hyperglycemia; Insulin Glargine; Isoindoles; Male; Monitoring, Physiologic; Sitagliptin Phosphate | 2015 |
Efficacy of mitiglinide and sitagliptin, alone or in combination, on postprandial excursion and glycemic variability assessed by continuous glucose monitoring: a post hoc analysis with single-day treatment.
Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Isoindoles; Male; Middle Aged; Postprandial Period; Prospective Studies; Pyrazines; Sitagliptin Phosphate; Triazoles | 2015 |
Differences between Mitiglinide/Voglibose Fixed-dose Combination and Glimepiride in Modifying Low-density Lipoprotein Heterogeneity in Japanese Type-2 Diabetic Patients: A Pilot Study.
Topics: Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Isoindoles; Japan; Lipoproteins, LDL; Male; Pilot Projects; Sulfonylurea Compounds | 2016 |
A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Insulin Glargine; Isoindoles; Male; Middle Aged; Prospective Studies | 2015 |
Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.
Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Hypoglycemic Agents; Inositol; Insulin; Insulin, Long-Acting; Isoindoles; Linagliptin; Male; Metformin; Middle Aged; Postprandial Period | 2017 |
Addition of mitiglinide to pioglitazone monotherapy improves overall glycemic control in Japanese patients with type 2 diabetes: a randomized double blind trial.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Isoindoles; Male; Middle Aged; Pioglitazone; Thiazolidinediones | 2009 |
Effect of mitiglinide on glycemic control over 52 weeks in Japanese type 2 diabetic patients insufficiently controlled with pioglitazone monotherapy.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Isoindoles; Male; Middle Aged; Pioglitazone; Thiazolidinediones; Time Factors; Weight Gain | 2009 |
Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Isoindoles; Male; Renal Dialysis; Treatment Outcome | 2010 |
Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Humans; Hypoglycemic Agents; Isoindoles; Male; Middle Aged; Renal Dialysis; Treatment Outcome | 2010 |
Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial.
Topics: Blood Glucose; Body Mass Index; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Isoindoles; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period; Treatment Outcome; Waist-Hip Ratio | 2012 |
Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Asian People; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glucagon; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Male; Middle Aged | 2012 |
Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients.
Topics: Antioxidants; Cross-Over Studies; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Indoles; Inflammation; Interleukin-18; Interleukin-6; Isoindoles; Oxidative Stress; Placebos; Postprandial Period; Tumor Necrosis Factor-alpha | 2005 |
Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus.
Topics: Adult; Age Factors; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Aspart; Insulin Glargine; Insulin, Long-Acting; Isoindoles; Male; Middle Aged; Postprandial Period; Time Factors | 2006 |
Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study.
Topics: Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Glargine; Insulin, Long-Acting; Isoindoles; Male; Middle Aged; Research Design; Time; Time Factors; Treatment Outcome | 2007 |
Effect of combination therapy of a rapid-acting insulin secretagogue (glinide) with premixed insulin in type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Isoindoles; Japan; Male; Middle Aged; Multicenter Studies as Topic; Nateglinide; Phenylalanine; Treatment Outcome | 2007 |
18 other study(ies) available for mitiglinide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Glucose Tolerance Test; Glyburide; Isoindoles; Male; Rats; Sitagliptin Phosphate | 2017 |
Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Isoindoles; Male; Obesity; Rats, Sprague-Dawley; Rats, Zucker | 2017 |
The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy.
Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Graves Ophthalmopathy; Humans; Hyperglycemia; Hypoglycemic Agents; Isoindoles; Male; Methylprednisolone; Middle Aged; Piperidines; Treatment Outcome | 2018 |
Gastroretentive Microsponge as a Promising Tool for Prolonging the Release of Mitiglinide Calcium in Type-2 Diabetes Mellitus: Optimization and Pharmacokinetics Study.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Delivery Systems; Drug Liberation; Hypoglycemic Agents; Isoindoles; Particle Size; Porifera; Rabbits | 2018 |
Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Insulin; Insulin Antibodies; Insulin Secretion; Isoindoles; Liraglutide; Male; Postprandial Period; Treatment Outcome | 2019 |
Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Isoindoles; Japan; Middle Aged; Oxidative Stress | 2013 |
The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Breakfast; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Insulin; Isoindoles; Lunch; Male; Meals; Middle Aged; Postprandial Period; Triglycerides | 2014 |
Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin; Isoindoles; Niacinamide; Rats; Rats, Zucker; Streptozocin | 2015 |
[Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy].
Topics: Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypoglycemic Agents; Isoindoles; Nateglinide; Phenylalanine | 2015 |
[Fixed-dose combination].
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Inositol; Isoindoles; Metformin; Pioglitazone; Piperidines; Sulfonylurea Compounds; Thiazolidinediones; Uracil | 2015 |
Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Isoindoles; Male; Sulfonylurea Compounds | 2015 |
Treatment with glimepiride, but not mitiglinide and short-acting insulin, resists body weight and abdominal fat reduction under dietary energy restriction.
Topics: Abdominal Fat; Body Weight; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Humans; Insulin; Isoindoles; Male; Middle Aged; Sulfonylurea Compounds | 2009 |
Effect of mitiglinide on Streptozotocin-induced experimental type 2 diabetic rats: a urinary metabonomics study based on ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Animals; Chromatography, Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Isoindoles; Male; Metabolomics; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2009 |
Mitiglinide treatment may decreases plasma fibroblast growth factor-21 levels in individuals with new-onset T2DM.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female; Fibroblast Growth Factors; Humans; Isoindoles; Male; Middle Aged | 2012 |
Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
Topics: ATP-Binding Cassette Transporters; Chlorpropamide; Cyclohexanes; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gliclazide; Glyburide; Haplotypes; Homozygote; Humans; Isoindoles; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Polymorphism, Single Nucleotide; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
[Pharmacological and clinical profile of mitiglinide calcium hydrate (Glufast), a new insulinotropic agent with rapid onset].
Topics: Animals; Diabetes Mellitus, Type 2; Dogs; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Rats | 2004 |
Characterization of the action of S 21403 (mitiglinide) on insulin secretion and biosynthesis in normal and diabetic beta-cells.
Topics: Animals; Arginine; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Gerbillinae; Glucose; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Insulin-Secreting Cells; Isoindoles; Perfusion; Rats; Rats, Wistar | 2005 |
Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Glyburide; Indoles; Insulin; Insulin Secretion; Isoindoles; Lipoprotein Lipase; Male; Nateglinide; Phenylalanine; Portal Vein; Postprandial Period; Prediabetic State; Rats; Rats, Inbred OLETF; RNA, Messenger; Sulfonylurea Compounds; Triglycerides | 2006 |